We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-2.16%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.1B
AUM Growth
-$223M
Cap. Flow
+$167M
Cap. Flow %
1.18%
Top 10 Hldgs %
50.49%
Holding
934
New
167
Increased
318
Reduced
289
Closed
160

Sector Composition

Rank Sector Weight
1 Energy 58.29%
2 Materials 3.15%
3 Healthcare 2.73%
4 Financials 2.46%
5 Industrials 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAHO
701
DELISTED
Tahoe Resources Inc
TAHO
$401K ﹤0.01%
76,133
+9,346
+14% +$50.9K
CW icon
702
Curtiss-Wright
CW
$27.7B
$398K ﹤0.01%
3,808
+429
+13% +$41.6K
HIW icon
703
Highwoods Properties
HIW
$3.71B
$395K ﹤0.01%
7,586
-1,025
-12% -$52.4K
EVTC icon
704
Evertec
EVTC
$1.83B
$391K ﹤0.01%
+24,697
New +$442K
ESRX
705
DELISTED
Express Scripts Holding Company
ESRX
$389K ﹤0.01%
6,149
+663
+12% +$41.2K
SVU
706
DELISTED
SUPERVALU Inc.
SVU
$383K ﹤0.01%
17,589
-5,908
-25% -$131K
RH icon
707
RH
RH
$3.3B
$382K ﹤0.01%
5,428
+642
+13% +$40.3K
URGN icon
708
UroGen Pharma
URGN
$2B
$372K ﹤0.01%
11,790
+984
+9% +$21.7K
WAFD icon
709
WaFd
WAFD
$2.72B
$360K ﹤0.01%
+10,691
New +$348K
ASRT
710
DELISTED
Assertio
ASRT
$359K ﹤0.01%
1,033
+96
+10% +$45.2K
IRBT
711
DELISTED
iRobot
IRBT
$359K ﹤0.01%
+4,665
New +$427K
CRBP icon
712
Corbus Pharmaceuticals
CRBP
$170M
$354K ﹤0.01%
1,649
+138
+9% +$27K
APA icon
713
APA Corp
APA
$12.8B
$346K ﹤0.01%
7,554
+1,671
+28% +$73.7K
MGI
714
DELISTED
MoneyGram International, Inc. New
MGI
$346K ﹤0.01%
21,456
+11,137
+108% +$180K
BFYT
715
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$345K ﹤0.01%
+23,822
New +$657K
AVY icon
716
Avery Dennison
AVY
$12.3B
$344K ﹤0.01%
3,496
-5,276
-60% -$496K
HUM icon
717
Humana
HUM
$46.7B
$331K ﹤0.01%
1,359
+131
+11% +$32.1K
CNCE
718
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$330K ﹤0.01%
22,343
+1,981
+10% +$28.7K
ACGN
719
DELISTED
Aceragen Inc
ACGN
$329K ﹤0.01%
1,085
+94
+9% +$24.6K
NGNE icon
720
Neurogene
NGNE
$696M
$328K ﹤0.01%
1,156
+101
+10% +$29K
ECL icon
721
Ecolab
ECL
$75.6B
$327K ﹤0.01%
2,540
+406
+19% +$53.4K
RARX
722
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$325K ﹤0.01%
22,267
+1,897
+9% +$28.7K
LMT icon
723
Lockheed Martin
LMT
$134B
$319K ﹤0.01%
1,027
+16
+2% +$4.77K
NERV icon
724
Minerva Neurosciences
NERV
$188M
$318K ﹤0.01%
5,233
+1,092
+26% +$62.6K
CNC icon
725
Centene
CNC
$31.3B
$313K ﹤0.01%
6,478
+718
+12% +$30.9K

Similar funds

ALPS Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, ALPS Advisors held 934 positions worth $14.1B, down 1.6% from $14.3B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

ALPS Advisors's Q3 2017 filing shows 167 new, 318 increased, 289 reduced and 160 closed positions. Its largest new stake was Holly Energy Partners, L.P.: 3,356,940 shares worth $112M. The largest sale was Oneok Partners LP, an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 58% of assets, down from 60% a quarter earlier, followed by Materials and Healthcare.

  • ALPS Advisors's largest Q3 2017 buy was Holly Energy Partners, L.P.: 3,356,940 shares worth $112M.
  • ALPS Advisors added most to MPLX in Q3 2017, an estimated $117M increase.
  • ALPS Advisors's biggest Q3 2017 reduction was People Inc, cutting an estimated $25.7M.
  • ALPS Advisors fully exited Oneok Partners LP in Q3 2017, selling an estimated $638M.
  • ALPS Advisors's ten largest holdings make up 50% of its $14.1B portfolio in Q3 2017.
  • ALPS Advisors opened 167 new positions and closed 160 in Q3 2017.
  • ALPS Advisors's portfolio value fell 1.6% quarter-over-quarter to $14.1B.

Based on ALPS Advisors's 13F filing for Q3 2017, filed 3 Nov 2017.